These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 20082609

  • 1. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E, Säkkinen H, Tokola H, Isopoussu E, Aro J, Leskinen H, Ruskoaho H, Rysä J.
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [Abstract] [Full Text] [Related]

  • 2. TWEAK is a positive regulator of cardiomyocyte proliferation.
    Novoyatleva T, Diehl F, van Amerongen MJ, Patra C, Ferrazzi F, Bellazzi R, Engel FB.
    Cardiovasc Res; 2010 Mar 01; 85(4):681-90. PubMed ID: 19887380
    [Abstract] [Full Text] [Related]

  • 3. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
    Chorianopoulos E, Heger T, Lutz M, Frank D, Bea F, Katus HA, Frey N.
    Basic Res Cardiol; 2010 Mar 01; 105(2):301-13. PubMed ID: 19629561
    [Abstract] [Full Text] [Related]

  • 4. A novel p38 MAPK target dyxin is rapidly induced by mechanical load in the heart.
    Luosujärvi H, Aro J, Tokola H, Leskinen H, Tenhunen O, Skoumal R, Szokodi I, Ruskoaho H, Rysä J.
    Blood Press; 2010 Feb 01; 19(1):54-63. PubMed ID: 20175653
    [Abstract] [Full Text] [Related]

  • 5. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells.
    Ando T, Ichikawa J, Wako M, Hatsushika K, Watanabe Y, Sakuma M, Tasaka K, Ogawa H, Hamada Y, Yagita H, Nakao A.
    Arthritis Res Ther; 2006 Feb 01; 8(5):R146. PubMed ID: 16945157
    [Abstract] [Full Text] [Related]

  • 6. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts.
    Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    Clin Exp Immunol; 2006 Dec 01; 146(3):540-9. PubMed ID: 17100776
    [Abstract] [Full Text] [Related]

  • 7. Expression of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor-inducible 14 protein (Fn14), in healthy tissues and in tissues affected by periodontitis.
    Kataria NG, Bartold PM, Dharmapatni AA, Atkins GJ, Holding CA, Haynes DR.
    J Periodontal Res; 2010 Aug 01; 45(4):564-73. PubMed ID: 20546112
    [Abstract] [Full Text] [Related]

  • 8. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T, Borodovsky A, Wu P, Shearstone JR, Kawashima R, Runkel L, Rajman L, Dong X, Scott ML, Michaelson JS, Jakubowski A, Burkly LC.
    Gastroenterology; 2009 Mar 01; 136(3):912-23. PubMed ID: 19109961
    [Abstract] [Full Text] [Related]

  • 9. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D, Fung JN, Tuo Y, Hu L, Chen C.
    Cancer Lett; 2010 Aug 01; 294(1):91-100. PubMed ID: 20189297
    [Abstract] [Full Text] [Related]

  • 10. Thrombospondin-4, tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14: novel extracellular matrix modulating factors in cardiac remodelling.
    Mustonen E, Ruskoaho H, Rysä J.
    Ann Med; 2012 Dec 01; 44(8):793-804. PubMed ID: 22380695
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Zhou J, Xu X, Liu JJ, Lin YX, Gao GD.
    Clin Exp Pharmacol Physiol; 2007 Nov 01; 34(11):1191-8. PubMed ID: 17880376
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of cardiac matrix Gla protein expression in response to hypertrophic stimuli.
    Mustonen E, Pohjolainen V, Aro J, Pikkarainen S, Leskinen H, Ruskoaho H, Rysä J.
    Blood Press; 2009 Nov 01; 18(5):286-93. PubMed ID: 19919401
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor-like weak inducer of apoptosis induces astrocyte proliferation through the activation of transforming-growth factor-α/epidermal growth factor receptor signaling pathway.
    Rousselet E, Traver S, Monnet Y, Perrin A, Mandjee N, Hild A, Hirsch EC, Zheng TS, Hunot S.
    Mol Pharmacol; 2012 Nov 01; 82(5):948-57. PubMed ID: 22909796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S, Nakajima A, Kamata K, Kurosawa H, Yagita H, Okumura K.
    Rheumatology (Oxford); 2008 Apr 01; 47(4):442-50. PubMed ID: 18310134
    [Abstract] [Full Text] [Related]

  • 18. p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat.
    See F, Thomas W, Way K, Tzanidis A, Kompa A, Lewis D, Itescu S, Krum H.
    J Am Coll Cardiol; 2004 Oct 19; 44(8):1679-89. PubMed ID: 15489104
    [Abstract] [Full Text] [Related]

  • 19. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
    Shui Y, Guan ZB, Zhang SQ.
    Vet Immunol Immunopathol; 2008 Dec 15; 126(3-4):396-402. PubMed ID: 18817982
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor antagonist blocks the expression of connexin43 induced by cyclical mechanical stretch in cultured neonatal rat cardiac myocytes.
    Shyu KG, Chen CC, Wang BW, Kuan P.
    J Mol Cell Cardiol; 2001 Apr 15; 33(4):691-8. PubMed ID: 11273722
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.